U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301437) titled 'RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.' on Dec. 11.
Brief Summary: To evaluate the differences in weight loss between liraglutide monotherapy and combined with orlistat in overweight/obese patients.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Overweight and Obese Adults
Intervention:
DRUG: liraglutide monotherapy
liraglutide monotherapy
DRUG: liraglutide combined with orlistat
combination therapy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Disclaimer: C...